February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Nov 14, 2024, 15:58

Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer

Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:

“Warning on Sotorasib Treatment for Advanced Lung Cancer.

Sotorasib, the first RAS inhibitor approved for KRASG12C-mutated NSCLC, showed improvements in progression-free survival (PFS) in the CodeBreaK 200 trial. However, in October 2023, the FDA rejected its regular approval, keeping its accelerated status pending confirmatory studies.

A 2023 commentary in The Lancet raises concerns about the trial’s statistical analysis and the absolute risks for PFS and overall survival (OS).

Transparency in these studies is essential to properly guide clinical practice.”

Iván R. González